Lymphoid interstitial pneumonia: Clinical features, associations and prognosis

European Respiratory Journal

Volumn 28, Issue 2, 2006, Pages 364-369

  Cha, S I ^a   Fessler, M B ^b   Cool, C D ^b   Schwarz, M I ^b   Brown, K K ^b  

^a Kyungpook National University Hospital   (South Korea)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Corticosteroid; Lymphoid interstitial pneumonia; Survival

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; COUGHING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSPNEA; DYSPROTEINEMIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNOPATHOLOGY; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTOSIS; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SURVIVAL TIME; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTOSIS; MALE; MIDDLE AGED; RARE DISEASES;

EID: 33845492413     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00076705     Document Type: Article

References (26)

1. Liebow A, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, eds. Frontiers of Pulmonary Radiology. 1st Edn. New York, Grune & Stratton, 1969; pp. 102-141.
2. Koss M, Hochholzer L, Langloss J, et al. Lymphoid interstitial pneumonia: clinicopathological and immunopathologic findings in 18 cases. Pathology 1987; 19: 178-185.
3. Koss MN. Pulmonary lymphoid disorders. Semin Diagn Pathol 1995; 12: 158-171.
4. Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301-1315.
5. Kradin RL, Young RH, Kradin LA, Mark EJ. Immunoblastic lymphoma arising in chronic lymphoid hyperplasia of the pulmonary interstitium. Cancer 1982; 50: 1339-1343.
6. Teruya-Feldstein J, Temeck BK, Sloas MM, et al. Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV positive patient. Am J Surg Pathol 1995; 19: 357-363.
7. Johkoh T, Muller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212: 567-572.
8. Liebow A, Carrington C. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973; 57: 809-843.
9. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
10. Travis WD, Galvin JR. Non-neoplastic pulmonary lymphoid lesions. Thorax 2001; 56: 964-971.
11. Strimlan CV, Rosenow EC 3rd, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis. Ann Intern Med 1978; 88: 616-621.
12. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133: 97-103.
13. Morris JF, Koski A, Johnson LC. Spirometric standards for healthy non-smoking adults. Am Rev Respir Dis 1971; 613: 57-67.
14. Goldman HI, Becklake MR. Respiratory function tests. Normal values at medium altitude and the prediction of normal results. Am Rev Tuberc 1959; 79: 457-467.
15. Ogilvie CM, Forster RE, Blakemore WS, Morton JW. A standardized breathholding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957; 36: 1-17.
16. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 123: 185-189.
17. Riley RL, Cournand A. Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. J Appl Physiol 1949; 1: 825-847.
18. Jones NL, Campbel EJM. Clinical Exercise Testing. Philadelphia, W.B. Saunders Co., 1982; p. 249.
19. Watters LC, King TE, Cherniack RM, et al. Bronchoalveolar lavage fluid neutrophils increase after corticosteroid therapy in smokers with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133: 104-109.
20. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-664.
21. Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr Opin Pulm Med 1996; 2: 429-433.
22. Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest 2002; 122: 2150-2164.
23. Nicholson AG, Wotherspoon AC, Diss TC, et al. Reactive pulmonary lymphoid disorders. Histopathology 1995; 26: 405-412.
24. Davies CWH, Gray W, Gleeson FV, Chapel HM, Davies RJO. Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinemia treated with cyclosporin A. Thorax 2000; 55: 88-90.
25. Lynch JP, McCune WJ. Immunosuppressive and cytotoxic pharmacology for pulmonary disorders. Am J Respir Crit Care Med 1997; 155: 395-420.
26. Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004; 114: 415-421.